ClinicalTrials.gg
CompletedNCT07332065Updated May 11, 2026

The Effects of Mandala Coloring on Women During Menopause

An interventional study of Mandala coloring in Menopause, Self Esteem and Sexual Activity, sponsored by Kahramanmaras Sutcu Imam University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-11.

Sponsored by Kahramanmaras Sutcu Imam University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
40 Years to 65 Years
Sex
Female
01

Study summary

The aim of this clinical study is to determine the effect of mandala coloring on menopausal symptoms, sexual quality of life, and self-esteem in women during menopause period. The main questions the study aims to answer are as follows:

  1. Does mandala coloring reduce the severity of menopausal symptoms in women?
  2. Is there an increase in self-esteem levels among women who participate in mandala coloring after the intervention?
  3. Is there an increase in the quality of sexual life among women who participate in mandala coloring after the intervention? Researchers will compare the intervention group (those who participated in mandala coloring) with the control group (those who did not participate in any intervention) to evaluate the effectiveness of mandala coloring.

Participants

  • Participants in the intervention group will attend 30-minute mandala coloring sessions once a week for 4 weeks.
  • Participants in the control group will not receive any intervention during the same period.
  • Both groups will be assessed using a questionnaire at the beginning of the study and at the end of the 4th week (pre-test/post-test).
Read the detailed description

Menopause is a natural, biological process that marks the end of a woman's fertile years. Every woman's menopause is unique. The experience, severity, duration, and physical and psychological effects of menopause are all unique. During this period, women must contend with both the processes of aging and the hormonal changes that occur during menopause. These changes can sometimes negatively impact an individual's life, reducing their quality of life. Menopausal symptoms can often appear one to two years before their last menstrual period and up to 15 years afterward. These symptoms, such as decreased sexual desire, decreased estrogen levels, mood disorders, illnesses associated with menstruation, decreased genital sensation, vaginal dryness, physical discomfort, and bone loss, can lead to a loss of sexual desire and alienate a person from their partner. This, in turn, leads to a decrease in self-esteem, a feeling of unease about one's own characteristics and ongoing physical and psychological changes. Consequently, individuals' anxiety levels increase, and their ability to cope with symptoms decreases. Studies have highlighted the benefits of alternative methods for coping with anxiety in women undergoing menopause. Music therapy and art therapy are examples. Studies have also demonstrated the therapeutic effects of mandala coloring, an art therapy activity. This study aims to examine the effects of mandala coloring on menopausal symptoms, quality of sexual life, and self-esteem in menopausal women.

02

Conditions studied

  • Menopause
  • Self Esteem
  • Sexual Activity
  • Women
  • Menopause Symptoms

Browse trials for

Keywords

  • menopause
  • menopause symptoms
  • self esteem
  • mandala coloring
  • sexual quality of life
  • mandala
03

In context

Sexual Behavior

224 studies on the registry are indexed under Sexual Behavior; 30 are open to participants now.

This study's enrollment of 70 is below the median of 264 across 179 interventional studies indexed under Sexual Behavior.

Browse Sexual Behavior studies →

Lead sponsor

Kahramanmaras Sutcu Imam University is the lead sponsor of 198 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being between the ages of 40 and 65,
  • Not having experienced menstruation for at least one year,
  • Having a score of 15 or higher on the MSDS (meaning having experienced at least moderate menopause),
  • Not having received hormone replacement therapy for menopausal symptoms,
  • Not having undergone surgical menopause,
  • Experiencing at least one vasomotor symptom of menopause (hot flashes, night sweats, sudden sweating attacks, palpitations, chills and shivering attacks, etc.).
  • Being able to read, write, speak, and understand Turkish,
  • Not having previously received mandala art therapy training or regularly practicing mandala coloring,
  • Not having an allergy to mandala coloring materials,
  • Not practicing spiritual practices such as yoga or meditation,
  • Agreeing to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Having a physical symptom that may prevent mandala coloring,
  • Having communication and perception problems,
  • Having difficulty understanding or speaking Turkish,
  • Having a psychiatric illness or taking psychiatric medication,
  • Having experienced a loss in the last 6 months.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Mandala coloring

    Participants will take part in 30-minute mandala painting sessions once a week for four weeks.

    Other: Mandala coloring

  • No intervention
    Control group

    No intervention will be applied to participants in the control group within 4 weeks.

Interventions

  • OtherMandala coloring

    Mandala coloring is a structured creative art activity based on colouring mandala shapes, which consist of circular and symmetrical patterns, increasing focus and promoting relaxation. As one of the art therapies, mandala colouring can have a therapeutic effect on individuals.

    Also known as: Mandala art activity

06

What researchers measure

Primary outcomes

  1. Menopausal Symptoms

    The primary outcome measure in this study is the severity of menopausal symptoms as assessed by the Menopause Rating Scale. This scale is an 11-item measure developed by Heineman et al. (1996) to assess the severity of menopausal symptoms. The minimum score that can be obtained on the scale is 0, while the maximum score is 44. An increase in the score obtained from the scale indicates an increase in the severity of the complaints experienced, while also showing that quality of life has been negatively affected. In this study, the validity and reliability of the scale in Turkish were conducted by Can Gürkan (2005). The Turkish version of the scale will be used. Within the scope of the current study, it is expected that women in menopause who engage in mandala coloring will show improvement in menopause symptoms. In other words, the Menopause Rating Scale scores of women in the experimental group will be lower than those of women who do not practice mandala coloring.

    Time frame: Time Frame: Fromenrollmenttotheend of intervention at 4 weeks.

Secondary outcomes

  1. Sexual Quality Of Life

    In this study, the secondary outcome measure is the level of sexual quality of life assessed using the Sexual Quality of Life Scale. The scale, developed by Symonds et al. (2005), consists of 18 items designed to measure women's sexual quality of life. Participants are expected to respond to the items based on their sexual life over the past four weeks. The lowest possible score on the scale is 18, and the highest possible score is 108. A higher score on the scale indicates a better quality of sexual life. The Sexual Quality of Life Scale - Female Turkish Form will be used in this study. Its validity and reliability in Turkish were conducted by Gölbaşı (2010). Within the scope of the current study, it is expected that women in menopause who practice mandala coloring will show an increase in their sexual life quality. In other words, the Sexual Life Quality Scale scores of the women in the experimental group are higher than those of women who do not practice mandala coloring.

    Time frame: Time Frame: From enrollment to the end of intervention at 4 weeks.

  2. Self-Esteem

    Another secondary outcome measure in this study is the level of self-esteem, assessed using the Coopersmith Self-Esteem Inventory Scale. The scale was developed by Stanley Coopersmith (1967). It consists of 25 items with opposite responses such as "Like me" or "Not like me." The content includes the person's outlook on life, family relationships, social relationships, and resilience. The lowest possible score on the scale is 0, and the highest is 25. A low score on the scale indicates low self-esteem, while a high score indicates high self-esteem. Turkish reliability and validity studies were conducted by Aksoy (1992) and Pişkin (1997). Within the scope of the study, it is expected that women in menopause who practice mandala coloring will experience an increase in their self-esteem levels. In other words, the scores obtained by the women in the experimental group on the Coopersmith Self-Esteem Inventory Scale are higher than those of women who do not practice mandala coloring.

    Time frame: Time Frame: From enrollment to the end of intervention at 4 weeks.

07

Study locations

1 site
  • Saçaklızade Family Health Center No. 30
    Kahramanmaraş, 46050, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2026 to primary completion in Feb 2026, 1 month.

Of 106 non-industry interventional studies with no phase under Sexual Behavior, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's 1 month is below that.

Counting every sponsor, half of 107 studies reached it within 23 months; a quarter within 11 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2025
First posted
Jan 12, 2026
StartActual
Jan 25, 2026
Primary completionActual
Feb 25, 2026
CompletionActual
Mar 25, 2026
Last update
May 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07332065
Responsible party
Kevser Katkaya (Principal Investigator, Kahramanmaras Sutcu Imam University) — Principal investigator
First posted
Jan 12, 2026
Start date
Jan 25, 2026
Primary completion
Feb 25, 2026
Completion
Mar 25, 2026
Last update
May 11, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion